↓ Skip to main content

Dove Medical Press

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

Overview of attention for article published in Drug Design, Development and Therapy, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
18 Mendeley
Title
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
Published in
Drug Design, Development and Therapy, May 2014
DOI 10.2147/dddt.s59594
Pubmed ID
Authors

Andreas O Doesch, Li Zhao, Christian A Gleissner, Mohammadreza Akhavanpoor, David Rohde, Deniz Okuyucu, Maani Hakimi, Thomas J Dengler, Hugo A Katus, Christian Erbel

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 22%
Student > Ph. D. Student 4 22%
Student > Master 2 11%
Researcher 1 6%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 6 33%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 22%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Medicine and Dentistry 2 11%
Biochemistry, Genetics and Molecular Biology 1 6%
Immunology and Microbiology 1 6%
Other 1 6%
Unknown 7 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2015.
All research outputs
#15,761,963
of 25,734,859 outputs
Outputs from Drug Design, Development and Therapy
#879
of 2,280 outputs
Outputs of similar age
#128,249
of 242,995 outputs
Outputs of similar age from Drug Design, Development and Therapy
#14
of 39 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,280 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,995 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.